Supreme Court Weighs Potential Impact of Oregon’s Drug Pricing Transparency Law
The U.S. Supreme Court recently sought the opinion of the Solicitor General on whether it should hear an appeal from the pharmaceutical industry challenging Oregon’s drug pricing transparency law. The law requires drugmakers to justify price increases, a mandate they argue threatens to reveal trade secrets and impacts competitive dynamics in the industry. This request…